The Department intends to (1) Change the term “prescribing practitioner” to “prescribing physician,” and amend the terminology throughout the rules and in form CF-FSP 5339, Medical Report; (2) Amend the definition of “psychotropic medication” to include substances, though prescribed with the intent to treat other medical conditions, have the effect of altering brain chemistry; (3) Amend the age of children whose cases are required to have a pre-consent review; and (4) Clarify from whom child protective investigators, case managers, and other caregivers will receive training.